Emergent Technologies, Inc. (ETI), a leading technology commercialization company, announced today the establishment of a new Board of Directors. With the appointments of Michael J. Maples, Glenn E. Nedwin and Robert C. Thomas to the new ETI Board, the company has made the move from internal board leadership to an outside, independent Board of Directors. ETI founder and CEO Thomas A. Harlan will continue to serve as Chairman of the Board.
“We are honored to have Michael Maples, Glen Nedwin and Robert Thomas join our Board of Directors,” said Thomas Harlan. “Given the recent multi-million dollar agreement between global healthcare leader Novo Nordisk and our portfolio company, Caisson Biotech, and with other large deals in the pipeline, we wanted to strengthen our team with proven, successful directors who will independently advise ETI and our portfolio of companies on strategies for growth, liquidation and value realization to our stakeholders,” stated Harlan. “The new board members are acclaimed executives in their respective fields and their leadership and forward thinking will be invaluable in helping us take ETI to the next level.”
A recognized technology expert, Michael Maples has more than 40 years experience as a senior executive in the computer industry. He retired from Microsoft Corporation where he served as Executive Vice President of the Worldwide Products Group and was a member of the Office of the President. Maples was responsible for all product development and product marketing activities at Microsoft during his tenure. Before joining Microsoft, Maples was employed with IBM for 23 years where he was Director of Software Strategy.
As a leading life sciences executive, Glenn Nedwin, Ph.D., MBA, has more than 30 years experience in pharmaceutical and industrial biotechnology industries. He is an accomplished senior executive with domestic and international experience involving start-up, growth and billion dollar organizations. Nedwin has held a number of scientific, corporate development and management positions, most notably as President of Novozymes, Inc., and as Executive Vice President of the Genencor Division of Danisco.
A key energy innovator, Robert Thomas’ career in the oil and gas industry spans more than 50 years. He joined Tenneco Gas in 1956 and in 34 years with the company held progressive engineering, management and executive positions. In 1990 Thomas was elected Chairman and Chief Executive Officer at Tenneco, a position he held until his retirement in 1994. From 1994 until 2002, Thomas was a senior associate with Cambridge Energy Research Associates focusing primarily on international energy issues.